CXCL10: a candidate biomarker in transplantation

Area of Science:

• Immunology
• Molecular Biology
• Transplantation Science

Background:

• C-X-C motif chemokine 10 (CXCL10), also known as Interferon gamma-induced protein 10 (IP-10), is a small cytokine involved in immune regulation.
• CXCL10 plays a critical role in immune-inflammatory processes by binding to its receptor CXCR3, regulating cell migration.
• This chemokine is implicated in the initiation and progression of various diseases, including allograft rejection.

Purpose of the Study:

• To review the critical role of CXCL10 in the pathogenesis of allograft rejection following organ transplantation.
• To highlight CXCL10's potential as a therapeutic target and a biomarker in transplantation.

Main Methods:

• Literature review focusing on the role of CXCL10 in allograft rejection.
• Analysis of studies correlating CXCL10 levels with immune response and graft outcomes.
• Examination of CXCL10's utility in monitoring transplant recipients.

Main Results:

• Enhanced CXCL10 production is observed in recipients of various organ transplants.
• Increased CXCL10 levels in circulation are associated with heightened immune responses and graft rejection.
• CXCL10 can be readily measured in patient serum and plasma.

Conclusions:

• CXCL10 is a significant factor in allograft rejection pathogenesis.
• Circulating CXCL10 levels can serve as a biomarker for immune status and rejection severity.
• Targeting CXCL10 offers potential therapeutic strategies and aids in fine-tuning patient management in transplantation.